(TGC) Time gain compensation is the signal processing control that allows the sonographer to amplify the returning signal from deeper structures in the body. The TGC control compensates for the attenuation of sound waves.

(TOF) Time of flight is a ultrasound technique used for calculating of the distance to a target by using the timing of the returning echo from the target and the speed of sound in the medium between the target and the sensor. Time of flight is used in echo location and ultrasonic flowmeters.

(THI) Tissue harmonic imaging (also called native harmonic imaging) is a signal processing technique which addresses ultrasound limitations like penetration and resolution. Tissue harmonic imaging reduces noise and clutter by improving signal to noise ratio and resolution. The signal penetration in soft tissue increases as the transmit frequency is decreased, by simultaneous decreased image resolution. As an ultrasound wave propagates through the target media a change occurs in the shape and frequency of the transmitted signal. The change is due to the normal resistance of tissue to propagate sound energy. This resistance and the resulting signal change is called a harmonic oscillation.
For harmonic imaging the input frequency doubles the output frequency, for example a transmit frequency of 3.0 MHz. which would provide maximum penetration will return a harmonic frequency of 6.0 MHz. The returning higher frequency signal has to only travel one direction to the probe. The advantages of high frequency imaging and the one-way travel effect are decreased reverberation, beam aberration, and side lobes, as well as increased resolution and cystic clearing.

Tissue-specific ultrasound contrast agents improve the image contrast resolution through differential uptake. The concentration of microbubble contrast agents within the vasculature, reticulo-endothelial, or lymphatic systems produces an effective passive targeting of these areas. Other contrast media concepts include targeted drug delivery via contrast microbubbles.
Tissue-specific ultrasound contrast agents are injected intravenously and taken up by specific tissues or they adhere to specific targets such as venous thrombosis. These effects may require minutes to several hours to reach maximum effectiveness. By enhancing the acoustic differences between normal and diseased tissues, these tissue-specific agents improve the detectability of abnormalities.
Some microbubbles accumulate in normal hepatic tissue; some are phagocytosed by Kupffer cells in the reticuloendothelial system and others may stay in the sinusoids. Liver tumors without normal Kupffer cells can be identified by the lack of the typical mosaic color pattern of the induced acoustic emission. The hepatic parenchymal phase, which may last from less than an hour to several days, depending on the specific contrast medium used, may be imaged by bubble-specific modes such as stimulated acoustic emission (color Doppler using high MI) or pulse inversion imaging.

Toshiba Medical Systems started 1914 and is now a leading diagnostic imaging manufacturer with departments including research, development, production, service and support of diagnostic imaging equipment and systems. 1976 Toshiba America Medical Systems, Inc. (TAMS) was founded to coordinate sales and service for previously established business operations in the USA.